Form 4: Herbalife Executive Henry C. Wang Reports Stock Transactions
SEC Form 4 Filing
Henry C. Wang, Chief Legal Officer of Herbalife Ltd., reports the acquisition of stock appreciation rights and the withholding of shares to cover tax obligations.
Summary
- On February 25, 2025, Henry C. Wang, Chief Legal Officer of Herbalife Ltd., reported transactions involving Herbalife stock.
- 2,527 shares of common stock were withheld to satisfy tax obligations related to the vesting of restricted stock units.
- These shares were withheld at a price of $8.29 per share.
- Following the transaction, Wang directly owns 159,517 shares of Herbalife common stock.
- Additionally, Wang was granted 77,433 stock appreciation rights (SARs) on February 21, 2025, with an exercise price of $8.31.
- These SARs vest in equal installments on February 21, 2026, February 21, 2027, and February 21, 2028, contingent upon continued service.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing and doesn't inherently convey positive or negative sentiment. It simply reports transactions.
Positives
- The granting of stock appreciation rights to a key executive could be seen as a positive incentive for future performance.
Future Outlook
The stock appreciation rights vest over the next three years, incentivizing continued service and potentially aligning executive compensation with company performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Investors monitor these filings to gain insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Stock appreciation rights are a common form of executive compensation, used by companies like Nu Skin Enterprises and USANA Health Sciences in the nutritional supplement industry.
- The vesting schedule of the SARs is fairly standard, with one-third vesting annually over three years, similar to practices at many publicly traded companies.
Stakeholder Impact
- Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.
- The granting of SARs could potentially align management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/21/2025 | Date of grant for stock appreciation rights (SARs) |
| 02/25/2025 | Date of transaction for tax withholding of shares |
| 02/21/2026 | First vesting date for one-third of the SARs |
| 02/21/2027 | Second vesting date for one-third of the SARs |
| 02/21/2028 | Final vesting date for one-third of the SARs |
| 02/21/2035 | Expiration date of the stock appreciation rights |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.